GH1 and prostate carcinoma: Additionally, 5α-reductase, which converts testosterone into dihydrotestosterone (DHT), plays a crucial role in androgen action at the tissue level, further impacting GH regulation and prostate cancer progression (Veldhuis et al., 2009).